Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer Neoadjuvant approaches for HER2-positive breast ...

A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a subset of head and neck cancer known as oropharyngeal cancer. A rare ...

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...

Neoadjuvant TKI therapy in non-metastatic GIST patients can reduce surgical complexity, with CE-CT imaging predicting benefits in 22 of 39 patients. Significant tumor volume reduction was observed ...

Potential guidance for decisions about treatment escalation, de-escalation ...

To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...

Patients with LARC within 12 cm from the anal verge and uninvolved MRF were randomly assigned to receive 4 cycles of CAPOX chemotherapy alone (nCT group) or CRT with concurrent Capecitabine (nCRT ...

A new study shows that clearing circulating tumor DNA (ctDNA) before breast cancer surgery strongly correlates with better treatment response and lower metastasis risk in triple-negative breast cancer ...

A daily vitamin D supplement may quietly supercharge chemotherapy. In a small study, women who took low doses alongside ...